Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 109.01 | 112.29 | 107.12 | 109.56 | 110.85 | 112.68 | 119.34 | 112.90 | 113.97 | 94.30 | 100.86 | 104.92 |
| Expenses | 104.32 | 105.64 | 99.65 | 102.77 | 102.61 | 105.14 | 110.43 | 105.67 | 106.21 | 88.46 | 95.16 | 99.47 |
| Operating Profit | 4.69 | 6.65 | 7.47 | 6.79 | 8.24 | 7.54 | 8.91 | 7.23 | 7.76 | 5.84 | 5.70 | 5.45 |
| OPM % | 4.30% | 5.92% | 6.97% | 6.20% | 7.43% | 6.69% | 7.47% | 6.40% | 6.81% | 6.19% | 5.65% | 5.19% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 2.94 | 2.00 | 2.72 | 2.24 | 2.67 | 2.50 | 3.40 | 2.29 | 2.10 | 2.10 | 2.34 | 1.84 |
| Depreciation | 0.58 | 0.32 | 0.32 | 0.02 | 0.60 | 0.02 | 0.64 | 0.33 | 0.33 | 0.34 | 0.34 | 0.32 |
| Profit before tax | 1.17 | 4.33 | 4.43 | 4.53 | 4.97 | 5.02 | 4.87 | 4.61 | 5.33 | 3.40 | 3.02 | 3.29 |
| Tax % | 31.62% | 28.18% | 29.80% | 32.23% | 30.38% | 31.87% | 25.87% | 32.10% | 30.77% | 31.76% | 38.74% | 33.74% |
| Net Profit | 0.80 | 3.11 | 3.11 | 3.07 | 3.46 | 3.41 | 3.61 | 3.13 | 3.69 | 2.31 | 1.85 | 2.17 |
| EPS in Rs | 0.01 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.04 | 0.03 | 0.04 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 342 | 384 | 396 | 419 | 451 | 419 | 414 |
| Expenses | 329 | 368 | 379 | 398 | 421 | 396 | 389 |
| Operating Profit | 13 | 17 | 16 | 21 | 30 | 24 | 25 |
| OPM % | 3.7% | 4.3% | 4.1% | 5% | 7% | 6% | 6% |
| Other Income | 1 | 0 | 1 | 1 | 2 | 3 | 0 |
| Interest | 12 | 10 | 10 | 10 | 11 | 9 | 8 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 6 | 6 | 11 | 19 | 16 | 15 |
| Tax % | 22% | 29% | 27% | 29% | 30% | 33% | |
| Net Profit | 0 | 4 | 4 | 8 | 14 | 11 | 10 |
| EPS in Rs | 0.01 | 0.09 | 0.07 | 0.13 | 0.24 | 0.19 | 0.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 4% | 2% | -9% | ||
| Compounded Profit Growth | % | 92% | 39% | -26% | ||
| Stock Price CAGR | -23% | -24% | -32% | -62% | ||
| Return on Equity | % | 6% | 7% | 7% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 18 | 21 | 26 | 26 | 32 | 32 |
| Reserves | 128 | 130 | 96 | 94 | 135 | 134 |
| Borrowings | 65 | 82 | 95 | 103 | 102 | 105 |
| Other Liabilities | 64 | 68 | 59 | 69 | 33 | 35 |
| Total Liabilities | 275 | 300 | 276 | 292 | 302 | 305 |
| Fixed Assets | 0 | 6 | 5 | 4 | 4 | 2 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 5 | 5 | 5 | 5 | 5 |
| Other Assets | 270 | 289 | 265 | 283 | 293 | 298 |
| Total Assets | 275 | 300 | 276 | 292 | 302 | 305 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -54 | 16 | 1 | 12 | -30 | 5 |
| Cash from Investing Activity | -0 | -7 | -0 | -0 | -0 | -0 |
| Cash from Financing Activity | 54 | -9 | -0 | -12 | 30 | -5 |
| Net Cash Flow | -0 | -0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -54 | 9 | 0 | 12 | -30 | 5 |
| CFO/OP | -429% | 111% | 20% | 64% | -76% | 64% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 266 | 255 | 223 | 225 | 196 | 214 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payable | ||||||
| Cash Conversion Cycle | 266 | 255 | 223 | 225 | 196 | 214 |
| Working Capital Days | 141 | 124 | 101 | 92 | 99 | 103 |
| ROCE % | 7% | 7% | 9% | 12% | 9% |
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.66% | 51.97% | 51.97% | 51.97% | 41.62% | 38.08% | 38.08% | 38.08% | 38.08% | 38.08% | 38.08% | 38.08% |
| FIIs | 0.02% | 0.02% | 0.01% | 0.04% | 0.35% | 0.31% | 0.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 40.31% | 48.01% | 48.03% | 47.99% | 58.04% | 61.61% | 61.59% | 61.92% | 61.93% | 61.92% | 61.92% | 61.92% |
| No. of Shareholders | 49,574 | 52,603 | 53,317 | 66,499 | 71,741 | 72,453 | 72,181 | 72,149 | 72,169 | 71,632 | 70,935 | 71,410 |
Fundamentals
Market Cap₹ 82.8 Cr.
Current Price₹ 1.44
Stock P/E8.26
Book Value₹ 2.89
ROCE9.34 %
ROE6.60 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-9%
Compounded Profit Growth (TTM)-26%
Consolidated figures.
Valuation
Market capRs 75 Cr
Enterprise valueRs 150 Cr
P/E (TTM)7.46x
Price to book0.50x
Price to sales0.18x
EV / EBITDA6.06x
EV / EBIT6.40x
EV / sales0.36x
Price to cash flow4.61x
Earnings yield13.41%
Profitability
Operating margin (excl. other income)4.30%
Operating margin (incl. other income)4.41%
EBITDA margin5.98%
Pre-tax margin3.63%
Net profit margin2.42%
Net margin, latest quarter2.07%
ROE3.00%
ROCE7.13%
ROA1.54%
ROIC (approx.)7.35%
Tax rate29.30%
Other income / net worth0.27%
Growth
Sales growth (latest year)12.40%
Profit growth (latest year)954.76%
Sales growth QoQ4.03%
Profit growth QoQ17.30%
Sales growth YoY (latest quarter)-7.07%
Profit growth YoY (latest quarter)-30.67%
Per share
EPS (TTM)Rs 0.17
EPS (latest year)Rs 0.22
EPS (latest quarter)Rs 0.04
Book value per shareRs 2.61
Sales per shareRs 7.20
Cash flow per shareRs 0.28
Free cash flow per shareRs 0.09
Efficiency
Asset turnover1.28x
Fixed asset turnover60.06x
Debtor days255 days
Debtors turnover1.43x
Cash conversion cycle214 days
Working capital days103 days
Leverage
Total debtRs 82 Cr
Cash and bankRs 7 Cr
Net debtRs 75 Cr
Debt to equity0.55x
Net debt / EBITDA3.04x
Interest coverage2.79x
Owners' fund to total sources49.98%
Debt to assets27.45%
Cash flow
Cash from Operating Activity (latest year)Rs 16 Cr
Cash from Investing Activity (latest year)Rs -7 Cr
Cash from Financing Activity (latest year)Rs -9 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 5 Cr
FCFE (approx.: FCF + change in debt)Rs 22 Cr
Cash from ops / profit, 5 years0.10x
Sales to cash flow23.73x
Statement figures
Net sales (TTM)Rs 414 Cr
Net sales (latest year)Rs 384 Cr
Sales (latest quarter)Rs 105 Cr
Operating profit excl. other income (latest year)Rs 17 Cr
Operating profit (latest quarter)Rs 5 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 25 Cr
PBDT (TTM)Rs 16 Cr
Profit before tax (TTM)Rs 15 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 10 Cr
Net profit (latest year)Rs 4 Cr
Net profit (latest quarter)Rs 2 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 8 Cr
Cost of goods sold (latest year)Rs 360 Cr
Total expenditure (latest year)Rs 368 Cr
Total income (latest year)Rs 385 Cr
Share capitalRs 21 Cr
ReservesRs 130 Cr
Shareholders' fundsRs 150 Cr
Total assetsRs 300 Cr
Net blockRs 6 Cr
InvestmentsRs 5 Cr
ReceivablesRs 268 Cr
Other liabilitiesRs 68 Cr
Shares outstanding (crore)57.49
Ownership
Promoter holding38.08% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | DUCON | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -20.7% | -2.8% | -18.0 pts |
| 1 month | -37.2% | -6.8% | -30.4 pts |
| 3 months | -59.8% | -7.6% | -52.1 pts |
| 6 months | -43.2% | +0.4% | -43.6 pts |
| 1 year | -76.8% | -9.9% | -66.9 pts |
| 2 years | -87.1% | -13.6% | -73.5 pts |
| 3 years | -81.9% | +14.2% | -96.1 pts |
| 5 years | -85.8% | +27.9% | -113.7 pts |
Red flags
F-score 6 of 8| explain | Weak cash conversion Cash from operations was -782% of net profit over the last 2 years |
| look | Share dilution Share count up 16% in a year |
| look | On NSE surveillance On NSE surveillance: ASM short-term |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹105 Cr -7.1% vs Jun 2025.
Net profit ₹2 Cr -30.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Indo-MIM Ltd | 61,719 | 95.6 | 25.0 % |
| Aditya Infotech Ltd | 46,814 | 98.1 | 28.6 % |
| Syrma SGS Technology Ltd | 32,638 | 87.9 | 16.8 % |
| Honeywell Automation India Ltd | 30,038 | 53.7 | 17.0 % |
| Jyoti CNC Automation Ltd | 24,091 | 74.9 | 21.3 % |
| Kaynes Technology India Ltd | 23,605 | 68.0 | 12.7 % |
| LMW Ltd | 18,115 | 99.2 | 5.58 % |
| Lloyds Engineering Works Ltd | 15,850 | 70.9 | 16.1 % |
| Tega Industries Ltd | 15,481 | 8.14 % | |
| Kennametal India Ltd | 8,878 | 45.3 | 33.2 % |
| Dynamatic Technologies Ltd | 8,873 | 151 | 10.2 % |
| Standard Engineering Technology Ltd | 8,557 | 100 | 14.7 % |
| Raymond Ltd | 7,894 | 46.9 | 3.14 % |
| Omnitech Engineering Ltd | 6,939 | 66.8 | 17.6 % |
| GMM Pfaudler Ltd | 6,641 | 52.7 | 13.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-08-25 | Rights 10:13 @ Premium Rs 0/- | |
| 2024-09-23 | Annual General Meeting | |
| 2024-08-30 | Rights 1:4 @ Premium Rs 6/- | |
| 2023-09-22 | Annual General Meeting | |
| 2022-09-22 | Annual General Meeting | |
| 2022-04-18 | Bonus 1:10 | 0.9091 |
| 2021-09-08 | Annual General Meeting | |
| 2020-09-22 | Annual General Meeting | |
| 2019-09-19 | Annual General Meeting | |
| 2018-09-19 | Annual General Meeting | |
| 2017-09-21 | Annual General Meeting | |
| 2016-09-22 | Annual General Meeting | |
| 2015-09-22 | Annual General Meeting | |
| 2014-09-22 | Annual General Meeting | |
| 2013-09-20 | Annual General Meeting |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Short Term Additional Surveillance Measure (Short Term ASM): stage 2